Pulmonx Corporation (LUNG) Reports In-Line Q1 EPS; Offers FY23 Revenue Guidance

Go back to Pulmonx Corporation (LUNG) Reports In-Line Q1 EPS; Offers FY23 Revenue Guidance
(NASDAQ: LUNG) Delayed: 2.00 +0.02 (1.01%)
Previous Close $1.98    52 Week High
Open $1.99    52 Week Low
Day High $2.03    P/E N/A 
Day Low $1.99    EPS
Volume 74,343